Do More With Reuters
Partner Services

UPDATE 1-CVS offers lower-cost fertility medications

Mon Nov 10, 2008 10:52pm IST
 
Email | Print | | Single Page
[-] Text [+]

(Adds CVS comments; byline)

By Jessica Wohl

CHICAGO, Nov 10 (Reuters) - CVS Caremark Corp (CVS.N: Quote, Profile, Research) said on Monday it is offering discounts of about 30 percent on fertility treatments to couples struggling with infertility and high medication costs.

The program is aimed at patients who do not have fertility medication health insurance coverage or who have exhausted their benefits for fertility medications.

CVS said about 7.3 million U.S. women and their partners, or about 12 percent of the reproductive-age population, are affected by infertility, citing data from the Centers for Disease Control and Prevention.

"On average patients will receive about 30 percent off for the cost of their medication," said Joan O'Rourke, vice president of strategic operations at CVS Caremark Specialty Pharmacy.

Patients must pay a $10 fee to enroll in the program, which includes services such as counseling and education.

While the program was launched in February, CVS is promoting it at the American Society of Reproductive Medicine's annual meeting this week.

Under a separate plan launched on Sunday, shoppers can get 90-day prescriptions for more than 400 common generic medications for $9.99 each at CVS drugstores when they pay an annual fee of $10.

About 45.7 million Americans were uninsured in 2007, according to the U.S. Census Bureau. (Reporting by Jessica Wohl; Editing by Tim Dobbyn)

Russian Finance Minister Alexey Kudrin poses with his G20 colleagues and central bank leaders during the family photo at the G20 Finance Ministers meeting at a hotel in St. Andrews, Scotland. REUTERS/POOL New
Pledge to support economies

G20 financial leaders pledged to prepare strategies to end emergency support for their economies, but to keep the aid flowing until recovery was assured.  Full Article | Related Story 

Market Update

  • IndiaIndia
  • USUS
  • UKUK
  • Asia
  • Most Actives

SHOWCASE

Sanjay Sinha
Balancing Act

In India, it is a tough choice between growth, managing inflation and financial stability.  Full Article 

 
Nipun Mehta
Road to Recovery

There needs to be an acceptable balance created between education and healthcare and infrastructure spend, says Nipun Mehta of SG Private Banking.   Full Article 

 
Robot Asimo

Snapshots of Honda Motor's humanoid robot Asimo  Slideshow 

 
Marketing Strategy
Marketing Strategy

Companies are now using direct marketing methods to sell their products.  Full Article 

 
Exit Plans
Exit Plans

Factbox - Stimulus exit plans for Asia-Pacific's big 5 economies  Full Article